According to Future Market Insights, the atypical hemolytic uremic syndrome (ahus) treatment market is anticipated to expand at a rate of 4.9% CAGR between 2023 and 2033. The therapy of Atypical Hemolytic Uremic Syndrome (Ahus) is predicted to have a US$ 2308.84 million market worth by 2033. The increasing incidence of the illness, growing knowledge of it …